人工授精市场规模、份额和成长分析（按类型、来源类型、最终用途、地区）：产业预测（2024-2031）

2022年全球人工授精市场规模估值为21亿美元，从2023年的22亿美元扩大到2031年的38亿美元，预计在预测期内（2024-2031年）复合年增长率为8.01%。

由于不孕率上升和对人工授精技术的需求不断增加，辅助生殖技术市场正经历显着成长。这种快速增长主要是由于生活方式的改变以及子宫内膜异位症和卵巢综合症（PCOS）等医疗状况的流行，这些疾病需要先进的生殖解决方案。此外，新兴国家对人工授精的接受度不断提高也支持了市场的扩张。改进的精子和卵子选择方法、冷冻保存技术和胚胎着床前基因检测等技术进步也在推动成长。此外，同性婚姻合法化、更广泛地接受 LGBTQ+ 父母身份以及捐赠精子和卵子等社会变化也在推动该行业向前发展。不孕症政策、意识和教育措施正在推动这一成长轨迹，同时对个人化治疗方案的需求不断增加。促进市场动态的其他因素包括生殖医学保险覆盖范围的扩大、由于职业偏好而推迟生育的趋势以及提供人工授精服务的诊所和医疗机构的激增。总而言之，这些因素代表了一个强劲且不断发展的市场环境，对于寻求辅助生殖技术的多元化人群来说，该环境变得更加包容和可及。

目录

介绍

• 分析目的
• 定义
• 市场范围

分析方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• PESTEL分析
• 宏观经济指标
• 贸易分析

全球人工授精市场规模（按类型）/复合年增长率（2024-2031）

• 子宫腔内人工授精
• 子宫颈内人工授精
• 阴道内人工授精
• 输卵管内授精

全球人工授精市场规模（依来源类型）/复合年增长率（2024-2031）

• 配偶间人工授精（AIH）
• 非婚人工授精（AID）

全球人工授精市场规模（依最终用户）/复合年增长率（2024-2031）

• 生育治疗诊所和其他设施
• 在家里

全球人工授精市场规模（按地区）/复合年增长率（2024-2031）

• 北美（按类型、来源、最终用户）
  • 美国
  • 加拿大
• 欧洲（按类型、来源、最终用户）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区（依类型、来源、最终用户）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲（按类型、来源、最终用户）
  • 巴西
  • 其他拉丁美洲
• 中东和非洲（按类型、来源、最终用户）
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益年增率比较（YoY）（2021-2023）

主要企业简介

• Genea Pty Limited
• Vitrolife
• Rinovum Women's Health, LLC
• Pride Angel
• HI-TECH SOLUTIONS
• FUJIFILM Irvine Scientific
• Kitazato Corporation
• Rocket Medical plc
• Conceivex, Inc.
• Genea Limited
• Genus plc.
• Zoetis Inc.
• ABS Global
• Hamilton Thorne Inc.
• Continental Genetics
• Select Series
• Neogen Corporations
• Agtech inc
• Imv Technologies
• TenderNeeds Fertility LLC

结论和建议

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The market for assisted reproductive technologies is experiencing significant growth, driven by a rise in infertility rates and an increasing demand for artificial insemination techniques. This surge is largely attributed to lifestyle changes and the prevalence of medical conditions such as endometriosis and polycystic ovary syndrome (PCOS), necessitating advanced reproductive solutions. Additionally, the growing acceptance of artificial insemination in developing countries further supports market expansion. Technological advancements like improved sperm and egg selection methods, cryopreservation techniques, and pre-implantation genetic testing are also fueling growth. Furthermore, societal changes, including the legalization of same-sex marriage and broader acceptance of LGBTQ+ parenthood, alongside the availability of donor sperm and eggs, are propelling the industry forward. Enabling policies, increased awareness, and educational initiatives regarding artificial insemination and infertility are contributing to this growth trajectory, along with a heightened demand for personalized treatment options. Other factors enhancing market dynamics include expanding insurance coverage for reproductive procedures, a trend toward delayed childbearing favoring professional aspirations, and the proliferation of clinics and medical institutions offering artificial insemination services. Collectively, these elements indicate a robust and evolving market landscape that is becoming more inclusive and accessible to a diverse range of individuals seeking reproductive assistance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Insemination Market Segmental Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Artificial Insemination Market

The rising infertility rates globally serve as a significant market driver for the Global Artificial Insemination market. As couples and individuals struggle with delayed conception due to changing lifestyles, environmental factors, and an increase in reproductive health disorders, the demand for assisted reproductive technologies has surged. Artificial insemination emerges as a vital solution for those unable to conceive naturally, fostering greater acceptance and awareness of fertility treatments. Furthermore, an increasing societal interest in advanced reproductive methods strengthens the market's growth potential, as more individuals actively seek out artificial insemination to achieve their reproductive aspirations. This trend solidifies its status as a necessity in modern reproductive healthcare.

Restraints in the Global Artificial Insemination Market

The global artificial insemination market faces significant restraint due to the high costs associated with treatment, which often surpasses the financial capacity of many individuals and couples, particularly in lower-income demographics. The expenses associated with multiple treatment cycles, medications, and supplementary medical procedures can be prohibitive, especially in regions with inadequate insurance coverage for infertility treatments. This financial barrier limits access to artificial insemination, creating disparities in reproductive healthcare access. To address this issue and broaden the market's reach, it is essential to implement strategies aimed at reducing costs and enhancing affordability, thus making these services accessible to a wider population.

Market Trends of the Global Artificial Insemination Market

The Global Artificial Insemination market is witnessing a significant trend driven by the increasing utilization of advanced reproductive technologies. Innovations in genetic screening, cryopreservation, and high-tech sperm processing techniques have enhanced conception rates while minimizing invasiveness. Notable advancements include preimplantation genetic testing, which screens embryos for genetic disorders, thereby offering couples greater confidence in their reproductive choices. Additionally, improvements in sperm freezing and thawing methods provide patients with more flexible options. This technological evolution aims to personalize treatment protocols and boost success rates, ultimately broadening the market's growth and meeting the rising demand for effective reproductive solutions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis

Global Artificial Insemination Market Size by Type & CAGR (2024-2031)

• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Global Artificial Insemination Market Size by Source Type & CAGR (2024-2031)

• AIH-Husband
• AID-Donor

Global Artificial Insemination Market Size by End User & CAGR (2024-2031)

• Fertility clinics & other facilities
• Home

Global Artificial Insemination Market Size by Region & CAGR (2024-2031)

• North America, (Type, Source, End User)
  • US
  • Canada
• Europe, (Type, Source, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Genea Pty Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rinovum Women's Health, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pride Angel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HI-TECH SOLUTIONS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kitazato Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rocket Medical plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conceivex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genus plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABS Global
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Select Series
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agtech inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imv Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TenderNeeds Fertility LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation